Table 3.
GSM number | Sample name | Group | Age | Sex |
---|---|---|---|---|
GSM4308223 | B_PFP_2 | BS | 26 | M |
GSM4308224 | B_PFP_6 | BS | 42 | M |
GSM4308225 | B_PFP_7 | BS | 29 | M |
GSM4308226 | B_PFP_8 | BS | 49 | M |
GSM4308227 | B_PFP_9 | BS | 46 | M |
GSM4308228 | B_PFP_10 | BS | 35 | M |
GSM4308229 | B_PFP_11 | BS | 47 | F |
GSM4308230 | B_PFP_14 | BS | 49 | F |
GSM4308231 | B_PFP_15 | BS | 38 | F |
GSM4308232 | B_PFP_16 | BS | 47 | M |
GSM4308233 | B_PFP_17 | BS | 44 | F |
GSM4308234 | B_PFP_18 | BS | 38 | F |
GSM4308235 | B_PFP_19 | BS | 43 | F |
GSM4308236 | B_PFP_21 | BS | 48 | F |
GSM4308237 | B_PFP_22 | BS | 52 | M |
GSM4308238 | B_PFP_23 | BS | 40 | M |
GSM4308239 | C_PFP_24 | HC | 40 | M |
GSM4308240 | C_PFP_25 | HC | 38 | M |
GSM4308241 | C_PFP_26 | HC | 35 | F |
GSM4308242 | C_PFP_27 | HC | 28 | M |
GSM4308243 | C_PFP_28 | HC | 40 | F |
GSM4308244 | C_PFP_30 | HC | 39 | F |
GSM4308245 | C_PFP_31 | HC | 38 | F |
GSM4308246 | C_PFP_32 | HC | 33 | F |
GSM4308247 | C_PFP_33 | HC | 30 | F |
GSM4308248 | C_PFP_34 | HC | 28 | M |
GSM4308249 | C_PFP_35 | HC | 35 | M |
GSM4308250 | C_PFP_36 | HC | 37 | F |
GSM4308251 | C_PFP_38 | HC | 38 | F |
GSM4308252 | C_PFP_39 | HC | 39 | M |
GSM4308253 | C_PFP_40 | HC | 37 | F |
GSM4308254 | C_PFP_41 | HC | 39 | F |
GSM4308255 | C_PFP_42 | HC | 40 | F |
GSM4308256 | C_PFP_43 | HC | 40 | F |
BS= Behçet's syndrome patients; HC= healthy controls; F= female; M= male; GSM= GEO sample accession number.